Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Opening of ATP sensitive potassium channels causes migraine attacks with aura

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. PET imaging of meningioma with 18F-FLT: a predictor of tumour progression

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Functional gene networks reveal distinct mechanisms segregating in migraine families

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history

    Research output: Contribution to journalReviewResearchpeer-review

  1. A novel homoplasmic mt-tRNAGlu m.14701C>T variant presenting with a partially reversible infantile respiratory chain deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Quantitative Muscle MRI and Clinical Findings in Women With Pathogenic Dystrophin Gene Variants

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Myopathy can be a key phenotype of membrin (GOSR2) deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Fatigue, physical activity and associated factors in 779 patients with myasthenia gravis

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Irina T Zaharieva
  • Michael G Thor
  • Emily C Oates
  • Clara van Karnebeek
  • Glenda Hendson
  • Eveline Blom
  • Nanna Witting
  • Magnhild Rasmussen
  • Michael T Gabbett
  • Gianina Ravenscroft
  • Maria Sframeli
  • Karen Suetterlin
  • Anna Sarkozy
  • Luigi D'Argenzio
  • Louise Hartley
  • Emma Matthews
  • Matthew Pitt
  • John Vissing
  • Martin Ballegaard
  • Christian Krarup
  • Andreas Slørdahl
  • Hanne Halvorsen
  • Xin Cynthia Ye
  • Lin-Hua Zhang
  • Nicoline Løkken
  • Ulla Werlauff
  • Mena Abdelsayed
  • Mark R Davis
  • Lucy Feng
  • Rahul Phadke
  • Caroline A Sewry
  • Jennifer E Morgan
  • Nigel G Laing
  • Hilary Vallance
  • Peter Ruben
  • Michael G Hanna
  • Suzanne Lewis
  • Erik-Jan Kamsteeg
  • Roope Männikkö
  • Francesco Muntoni
View graph of relations

Congenital myopathies are a clinically and genetically heterogeneous group of muscle disorders characterized by congenital or early-onset hypotonia and muscle weakness, and specific pathological features on muscle biopsy. The phenotype ranges from foetal akinesia resulting in in utero or neonatal mortality, to milder disorders that are not life-limiting. Over the past decade, more than 20 new congenital myopathy genes have been identified. Most encode proteins involved in muscle contraction; however, mutations in ion channel-encoding genes are increasingly being recognized as a cause of this group of disorders. SCN4A encodes the α-subunit of the skeletal muscle voltage-gated sodium channel (Nav1.4). This channel is essential for the generation and propagation of the muscle action potential crucial to muscle contraction. Dominant SCN4A gain-of-function mutations are a well-established cause of myotonia and periodic paralysis. Using whole exome sequencing, we identified homozygous or compound heterozygous SCN4A mutations in a cohort of 11 individuals from six unrelated kindreds with congenital myopathy. Affected members developed in utero- or neonatal-onset muscle weakness of variable severity. In seven cases, severe muscle weakness resulted in death during the third trimester or shortly after birth. The remaining four cases had marked congenital or neonatal-onset hypotonia and weakness associated with mild-to-moderate facial and neck weakness, significant neonatal-onset respiratory and swallowing difficulties and childhood-onset spinal deformities. All four surviving cohort members experienced clinical improvement in the first decade of life. Muscle biopsies showed myopathic features including fibre size variability, presence of fibrofatty tissue of varying severity, without specific structural abnormalities. Electrophysiology suggested a myopathic process, without myotonia. In vitro functional assessment in HEK293 cells of the impact of the identified SCN4A mutations showed loss-of-function of the mutant Nav1.4 channels. All, apart from one, of the mutations either caused fully non-functional channels, or resulted in a reduced channel activity. Each of the affected cases carried at least one full loss-of-function mutation. In five out of six families, a second loss-of-function mutation was present on the trans allele. These functional results provide convincing evidence for the pathogenicity of the identified mutations and suggest that different degrees of loss-of-function in mutant Nav1.4 channels are associated with attenuation of the skeletal muscle action potential amplitude to a level insufficient to support normal muscle function. The results demonstrate that recessive loss-of-function SCN4A mutations should be considered in patients with a congenital myopathy.

Original languageEnglish
JournalBrain
Volume139
Pages (from-to)674-691
ISSN0006-8950
DOIs
Publication statusPublished - 2016

ID: 46211225